COLTENE Holding AG (SWX:CLTN)
Switzerland · Delayed Price · Currency is CHF 57.80
-0.20 (-0.34%)
Feb 20, 2026, 5:31 PM CET
COLTENE Holding AG Market Cap
COLTENE Holding AG has a market cap or net worth of 346.57 million as of February 20, 2026. Its market cap has increased by 5.07% in one year.
Market Cap
346.57M
Enterprise Value
381.13M
Revenue
240.71M
Ranking
n/a
PE Ratio
24.25
Stock Price
57.80
Market Cap Chart
Since June 23, 2006, COLTENE Holding AG's market cap has decreased from 435.24M to 346.57M, a decrease of -20.37%. That is a compound annual growth rate of -1.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 346.57M | 8.01% |
| Dec 30, 2025 | 320.88M | 4.48% |
| Dec 30, 2024 | 307.13M | -28.21% |
| Dec 29, 2023 | 427.85M | -6.04% |
| Dec 30, 2022 | 455.33M | -32.21% |
| Dec 30, 2021 | 671.65M | 30.70% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 294.66B |
| Novartis AG | 244.97B |
| Lonza Group AG | 37.02B |
| Galderma Group AG | 35.80B |
| PolyPeptide Group AG | 861.08M |
| Basilea Pharmaceutica AG | 684.45M |
| Newron Pharmaceuticals | 420.31M |
| IVF Hartmann Holding AG | 350.06M |